Search by Drug Name or NDC
NDC 24208-0464-10 BRINZOLAMIDE 10 mg/mL Details
BRINZOLAMIDE 10 mg/mL
BRINZOLAMIDE is a OPHTHALMIC SUSPENSION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is BRINZOLAMIDE.
MedlinePlus Drug Summary
Ophthalmic Brinzolamide is used to treat glaucoma, a condition that increases pressure in the eye and leads to vision loss. Brinzolamide is in a class of medications called carbonic anhydrase inhibitors. It decreases the pressure in the eye.
Related Packages: 24208-0464-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Brinzolamide Ophthalmic
Product Information
NDC | 24208-0464 |
---|---|
Product ID | 24208-464_9702bb56-cb22-450f-bb4c-a5a7714774a3 |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | BRINZOLAMIDE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | brinzolamide |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SUSPENSION/ DROPS |
Route | OPHTHALMIC |
Active Ingredient Strength | 10 |
Active Ingredient Units | mg/mL |
Substance Name | BRINZOLAMIDE |
Labeler Name | Bausch & Lomb Incorporated |
Pharmaceutical Class | Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA204884 |
Listing Certified Through | 2024-12-31 |
Package
NDC 24208-0464-10 (24208046410)
NDC Package Code | 24208-464-10 |
---|---|
Billing NDC | 24208046410 |
Package | 1 BOTTLE, PLASTIC in 1 CARTON (24208-464-10) / 10 mL in 1 BOTTLE, PLASTIC |
Marketing Start Date | 2022-03-31 |
NDC Exclude Flag | N |
Pricing Information | N/A |